|
AURA Aura Biosciences Inc 1501796 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-33,685,000.00 |
| Balance Sheet |
|
Current Assets
|
$118,504,000.00 |
|
Assets
|
$137,677,000.00 |
|
Current Liabilities
|
$16,706,000.00 |
|
Liabilities
|
$30,430,000.00 |
|
Equity
|
$107,247,000.00 |
|
Shares Out
|
64150468.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-29,893,000.00 |
|
Investing Cash Flow
|
$54,898,000.00 |
| Market Analysis |
Market Cap
|
$456,109,827.48 |
|
Price
|
$6.83 |
|
BVPS
|
1.67 |
|
PB
|
4.26 |
|
EPS
|
-0.50 |
|
FCF
|
$-29,995,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:28 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:24 |
|
| Apr |
May |
Jun |
| 2026-03-30 |
-1.76 |
|
|
2026-05-11 |
-0.50 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-13 |
-0.47 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-13 |
-0.40 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view AURA documents filed with the SEC.
AURA Filings
Clear
